FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

3188811000001106: Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25750301000001112 Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65961501000001116 Xatral XL 10mg tablets (Sanofi) 30 tablet 3 x 10 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Is a Alfuzosin 10mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Is pack of Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Alfuzosin hydrochloride true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has active ingredient Alfuzosin hydrochloride false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has AMP Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) true Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient Alfuzosin hydrochloride false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Xatral XL 10mg tablets (Sanofi-Synthelabo Ltd) 30 tablet 3 x 10 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start